|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.14 EUR | +0.27% |
|
-3.51% | +8.50% |
| 06-18 | Swiss trade surplus at CHF 6.11 bln in May | RE |
| 06-17 | Medpace: At the Heart of the Small-Cap Biopharma Crisis |  |
| Market Cap | 268B 234B 217B 203B 380B 25,304B 382B 2,569B 996B 12,455B 1,007B 985B 43,247B | P/E 2026 * |
20.3x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 300B 262B 243B 227B 426B 28,348B 429B 2,878B 1,115B 13,953B 1,128B 1,104B 48,450B | EV / Sales 2026 * |
5.27x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.05% | Yield 2027 * | 3.14% |
Last Transcript: Novartis AG
| 1 day | +0.27% | ||
| 1 week | -3.51% | ||
| Current month | -1.40% | ||
| 1 month | -0.71% | ||
| 3 months | +0.88% | ||
| 6 months | +9.99% | ||
| Current year | +8.50% |
| 1 week | 127.1 |  | 134 |
| 1 month | 121.98 | | 134 |
| Current year | 116.12 | | 144.08 |
| 1 year | 96.8 | | 144.08 |
| 3 years | 94.56 | | 144.08 |
| 5 years | 94.56 | | 144.08 |
| 10 years | 62.12 | | 144.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.27% | -3.51% | - | - | 268B | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| -2.74% | -3.82% | +5.57% | -37.07% | 144B | |
| Average | -0.54% | -3.08% | +17.03% | +32.33% | 353.09B | |
| Weighted average by Cap. | -0.86% | -3.72% | +27.09% | +61.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.02B 49.71B 46.04B 43.1B 80.83B 5,380B 81.32B 546B 212B 2,648B 214B 209B 9,195B | 60.42B 52.68B 48.79B 45.68B 85.67B 5,702B 86.18B 579B 224B 2,806B 227B 222B 9,745B |
| Net income | 14.15B 12.34B 11.43B 10.7B 20.06B 1,335B 20.18B 136B 52.53B 657B 53.11B 51.97B 2,282B | 15.67B 13.66B 12.66B 11.85B 22.22B 1,479B 22.35B 150B 58.19B 728B 58.83B 57.57B 2,527B |
| Net Debt | 32.26B 28.13B 26.05B 24.39B 45.74B 3,044B 46.01B 309B 120B 1,498B 121B 118B 5,203B | 28.3B 24.67B 22.85B 21.39B 40.12B 2,670B 40.36B 271B 105B 1,314B 106B 104B 4,564B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 128.14 € | +0.27% | 1,617 |
| 26-06-18 | 127.80 € | -2.81% | 1,835 |
| 26-06-17 | 131.50 € | +1.15% | 749 |
| 26-06-16 | 130.00 € | -0.61% | 415 |
| 26-06-15 | 130.80 € | -1.51% | 2,536 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NOT Stock
Select your edition
All financial news and data tailored to specific country editions
